Prevalence of prediabetes in England from 2003 to 2011: Population-based, cross-sectional study

BMJ Open

Volumn 4, Issue 6, 2014, Pages

  Mainous III, Arch G ^a   Tanner, Rebecca J ^a   Baker, Richard ^a   Zayas, Cilia E ^a   Harle, Christopher A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; ETHNIC DIFFERENCE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PREVALENCE; RACE DIFFERENCE; SEX DIFFERENCE; SOCIAL ISOLATION; SOCIAL STATUS; UNITED KINGDOM; ENGLAND; PREDIABETIC STATE; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; HUMANS; MALE; PREDIABETIC STATE; PREVALENCE; TIME FACTORS; YOUNG ADULT;

EID: 84902513825     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005002     Document Type: Article

References (28)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35:S64-71.
2. Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 2010;55:1310-17.
3. Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the US population implications for diabetes diagnostic thresholds. Diabetes Care 2009;32:2027-32.
4. Nathan DM, Chew E, Christophi CA, et al. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabetic Med 2007;24:137-44. (Pubitemid 46174936)
5. Ziegler D, Rathmann W, Dickhaus T, et al. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008;31:464-9.
6. Plantinga LC, Crews DC, Coresh J, et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol 2010;5:673-82.
7. Morris DH, Khunti K, Achana F, et al. Progression rates from HbA (1c) 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 2013;56:1489-93.
8. Tabak AG, Herder C, Rathmann W, et al. Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279-90.
9. Perreault L, Pan Q, Mather KJ, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379:2243-51.
10. Schellenberg ES, Dryden DM, Vandermeer B, et al. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 2013;159:543-51.
11. Assoc AD. Standards of medical care in diabetes-2013. Diabetes Care 2013;36:S11-66.
12. Krogsboll LT, Jorgensen KJ, Larsen CG, et al. General health checks in adults for reducing morbidity and mortality from disease: cochrane systemic review and meta-analysis. BMJ 2012;345:e7191.
13. McCartney M. Too Much Medicine where's the evidence for NHS health checks? BMJ 2013;347:f5834.
14. Glasziou P, Moynihan R, Richards T, et al. Too much medicine; too little care. BMJ 2013;347:f4247.
15. Heath I. Overdiagnosis: when good intentions meet vested interests - an essay by Iona Heath. BMJ 2013;347:f6361.
16. Gilmore AB, Savell E, Collin J. Public health, corporations and the new responsibility deal: promoting partnerships with vectors of disease? J Public Health 2011;33:2-4.
17. UK Faculty of Public Health. Responsibility deal pledge on fat is a drop in the ocean, 2013. http://www.fph.org.uk/responsibility-deal-pledge-on-fat-is- a-drop-in-the-ocean (accessed 6 Nov 2013).
18. Danaei G, Finucane MM, Lu Y, et al . National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31-40.
19. Bullard KM, Saydah SH, Imperatore G, et al . Secular changes in US prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999-2010. Diabetes Care 2013;36:2286-93.
20. Xu Y, Wang LM, He J, et al . Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948-58.
21. Chiu M, Austin PC, Manuel DG, et al. Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007. Can Med Assoc J 2010;182:E301-10.
22. McNeely MJ, Boyko EJ. Type 2 diabetes prevalence in Asian Americans. Diabetes Care 2004;27:66-9.
23. Donato KA, Pi-Sunyer FX, Becker DM, et al. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-67. (Pubitemid 28440858)
24. Gholap N, Davies M, Patel K, et al . Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes 2011;5:45-56.
25. Public Health England. NHS Health Check Implementation review and action plan, 2013. https://http://www.gov.uk/government/publications/nhs-health-check- implementation-review-and-action-plan (accessed 6 Nov 2013).
26. Davies SC. Annual report of the Chief Medical Office, Surveillance Volume, 2012: on the state of the public's health. London: Department of Health, 2014.
27. The University of Leicester and The UK National Screening Committee. The handbook for vascular risk assessment, risk reduction, and risk management. 2012 (updated). http://www.screening.nhs.uk/publications (accessed 1 Nov 2013).
28. Howel D. Trends in the prevalence of obesity and overweight in English adults by age and birth cohort, 1991-2006. Public Health Nutr 2011;14:27-33.